C. Bulaï Livideanu

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano et al. · Nature · 2011 · 522 citations

Medicine, Genetics, Oncology +14

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

Olivier Lortholary, Marie‐Olivia Chandesris, C. Bulaï Livideanu et al. · The Lancet · 2017 · 122 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +6

In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells

Erinn Soucié, Katia Hanssens, Thomas Mercher et al. · Blood · 2012 · 99 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

Calculation of cut‐off values based on the Autoimmune Bullous Skin Disorder Intensity Score ( <scp>ABSIS</scp> ) and Pemphigus Disease Area Index ( <scp>PDAI</scp> ) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus

C. Boulard, S. Duvert Lehembre, C. Picard‐Dahan et al. · British Journal of Dermatology · 2016 · 92 citations · Full text

Medicine, Dermatology, Autoimmunity +16

GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis

M. Larsabal, S. Ly, É. Sbidian et al. · British Journal of Dermatology · 2018 · 78 citations

Medicine, Dermatology, Andrology +9